0001140361-16-058277.txt : 20160317 0001140361-16-058277.hdr.sgml : 20160317 20160317172449 ACCESSION NUMBER: 0001140361-16-058277 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160315 FILED AS OF DATE: 20160317 DATE AS OF CHANGE: 20160317 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Arbutus Biopharma Corp CENTRAL INDEX KEY: 0001447028 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980597776 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100-8900 GLENLYON PARKWAY CITY: BURNABY STATE: A1 ZIP: V5J 5J8 BUSINESS PHONE: 604-419-3200 MAIL ADDRESS: STREET 1: 100-8900 GLENLYON PARKWAY CITY: BURNABY STATE: A1 ZIP: V5J 5J8 FORMER COMPANY: FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS Corp DATE OF NAME CHANGE: 20110607 FORMER COMPANY: FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS CORP DATE OF NAME CHANGE: 20081003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Howard Elizabeth CENTRAL INDEX KEY: 0001669530 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34949 FILM NUMBER: 161513348 MAIL ADDRESS: STREET 1: 100-8900 GLENLYON PARKWAY CITY: BURNABY STATE: A1 ZIP: V5J 5J8 4 1 doc1.xml FORM 4 X0306 4 2016-03-15 0 0001447028 Arbutus Biopharma Corp ABUS 0001669530 Howard Elizabeth C/O ARBUTUS BIOPHARMA CORP. SUITE 100, 8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 BRITISH COLUMBIA, CANADA 0 1 0 0 Exec. VP & General Counsel Employee Stock Option (Right to Buy) 3.94 2016-03-15 4 A 0 120000 0.0 A 2026-03-07 Common Shares 120000 120000 D The options vest as follows: 1/3 on March 7, 2017; 1/3 on March 7, 2018; and 1/3 on March 7, 2019. /s/ Elizabeth Howard 2016-03-16